Invivyd (IVVD) Return on Assets Growth (3y) (2024 - 2025)

Invivyd (IVVD) Return on Assets Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Nanobiotix 1,785.82 Bn 1,785.76 Bn -
2 Akari Therapeutics 979.03 Bn 979.03 Bn -
3 BeOne Medicines 472.86 Bn 468.07 Bn 1.35 Bn
4 Vertex Pharmaceuticals 123.71 Bn 116.47 Bn 2.59 Bn
5 Regeneron Pharmaceuticals 71.61 Bn 62.86 Bn 3.31 Bn
6 Belite Bio 62.00 Bn 62.00 Bn -
7 Argenx Se 54.62 Bn 49.44 Bn 1.41 Bn
8 Alnylam Pharmaceuticals 38.09 Bn 35.08 Bn 959.66 Mn
9 Revolution Medicines 36.08 Bn 36.08 Bn -
10 Invivyd 102.90 Mn -123.79 Mn 16.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 1.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00